American Century Companies’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $871K | Buy |
107,052
+882
| +0.8% | +$7.18K | ﹤0.01% | 2341 |
|
|
2025
Q1 | $833K | Buy |
106,170
+8,406
| +9% | +$66K | ﹤0.01% | 2310 |
|
|
2024
Q4 | $1.46M | Buy |
97,764
+9,782
| +11% | +$146K | ﹤0.01% | 2122 |
|
|
2024
Q3 | $1.35M | Buy |
87,982
+17,065
| +24% | +$261K | ﹤0.01% | 2129 |
|
|
2024
Q2 | $1.08M | Buy |
70,917
+13,019
| +22% | +$198K | ﹤0.01% | 2150 |
|
|
2024
Q1 | $1.09M | Buy |
57,898
+6,139
| +12% | +$116K | ﹤0.01% | 2111 |
|
|
2023
Q4 | $989K | Sell |
51,759
-405,936
| -89% | -$7.75M | ﹤0.01% | 2068 |
|
|
2023
Q3 | $8.22M | Buy |
457,695
+13,373
| +3% | +$240K | 0.01% | 1141 |
|
|
2023
Q2 | $9.02M | Buy |
444,322
+299,685
| +207% | +$6.09M | 0.01% | 1100 |
|
|
2023
Q1 | $2.63M | Buy |
144,637
+13
| +0% | +$236 | ﹤0.01% | 1507 |
|
|
2022
Q4 | $2.99M | Buy |
144,624
+2,224
| +2% | +$46K | ﹤0.01% | 1429 |
|
|
2022
Q3 | $3.73M | Buy |
142,400
+33
| +0% | +$863 | ﹤0.01% | 1220 |
|
|
2022
Q2 | $3.61M | Buy |
142,367
+24,652
| +21% | +$625K | ﹤0.01% | 1225 |
|
|
2022
Q1 | $3.72M | Buy |
117,715
+1,911
| +2% | +$60.3K | ﹤0.01% | 1203 |
|
|
2021
Q4 | $4.69M | Buy |
115,804
+88,904
| +330% | +$3.6M | ﹤0.01% | 1078 |
|
|
2021
Q3 | $938K | Buy |
26,900
+17,776
| +195% | +$620K | ﹤0.01% | 1620 |
|
|
2021
Q2 | $251K | Sell |
9,124
-22,737
| -71% | -$625K | ﹤0.01% | 2132 |
|
|
2021
Q1 | $895K | Buy |
31,861
+12,002
| +60% | +$337K | ﹤0.01% | 1479 |
|
|
2020
Q4 | $516K | Buy |
+19,859
| New | +$516K | ﹤0.01% | 1544 |
|
|
2019
Q1 | – | Sell |
-32,717
| Closed | -$352K | – | 1299 |
|
|
2018
Q4 | $352K | Buy |
+32,717
| New | +$352K | ﹤0.01% | 1159 |
|